Literature DB >> 9302394

Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment.

F Nyström1, B Ekman, M Osterlund, T Lindström, K P Ohman, H J Arnqvist.   

Abstract

OBJECTIVE: To study relationships between leptin and factors regulating body composition as well as metabolic risk factors. Furthermore, to study the effects of GH on leptin.
DESIGN: Cross-sectional and population-based. Regarding the effects of GH, prospective and interventional. PATIENTS: One hundred and eleven women and 107 men, 20-70 years old, randomly selected from the population registry in the community of Linköping, Sweden. Ten GH-deficient subjects were given GH until normalization of IGF-I levels. MEASUREMENTS: Venous blood was drawn in the fasting state. Serum leptin and hormones were analysed by immunoassay.
RESULTS: In the population sample the natural logarithm of leptin (in(leptin)) correlated with body mass index (BMI) (men, r = 0.67), P < 0.0001; women, r = 0.71, P < 0.0001). The median value of leptin was 4.6 micrograms/l in men and 12.3 micrograms/l in women (P < 0.0001). Levels of in(leptin) did not correlate with plasma neuropeptide Y (men, P = 0.13; women, P = 0.35). In men only there was an inverse relationship between in(leptin) and testosterone (r = -0.46, P < 0.0001, after correction for BMI standardized r = -0.26, P = 0.03) as well as IGF-I (r = -0.20, P = 0.048). Although BMI was similar, smoking men had higher leptin levels than non-smoking men (median, 6.6 and 4.2 micrograms/l, respectively; Mann-Whitney; P = 0.006). In the GH-deficient subjects leptin levels were elevated and, although GH treatment did not change BMI, leptin levels decreased (median before GH, 21 micrograms/l and after 15 micrograms/l, respectively; P = 0.017).
CONCLUSION: Serum leptin concentration is closely associated with BMI in the population with a gender difference in absolute levels and a strong negative correlation with testosterone in men. Serum leptin is elevated in GH deficiency and lowered by GH substitution.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302394     DOI: 10.1046/j.1365-2265.1997.2281039.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Endocrine disrupting chemicals: Multiple effects on testicular signaling and spermatogenesis.

Authors:  Bonnie Hy Yeung; Hin T Wan; Alice Ys Law; Chris Kc Wong
Journal:  Spermatogenesis       Date:  2011-07-01

2.  Association Between Gingival Crevicular Fluid Leptin Levels and Periodontal Status - A Biochemical Study on Indian Patients.

Authors:  Shalini Selvarajan; Rajapriya Perumalsamy; Pamela Emmadi; Ramakrishnan Thiagarajan; Ambalavanan Namasivayam
Journal:  J Clin Diagn Res       Date:  2015-05-01

Review 3.  Leptin and the pituitary.

Authors:  V Popovic; S Damjanovic; C Dieguez; F F Casanueva
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

4.  Leptin after IGF-I generation test in a patient with hypopituitarism and myotonic dystrophy disease.

Authors:  J M Gómez; J A Martínez-Matos
Journal:  Pituitary       Date:  1999       Impact factor: 4.107

5.  Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α and ghrelin levels in growth hormone-deficient children.

Authors:  J P López-Siguero; L F López-Canti; R Espino; E Caro; J M Fernández-García; A Gutiérrez-Macías; J M Rial; J L Lechuga; F Macías; M J Martínez-Aedo; S Rico; I Rodríguez; J Guillén; F J Arroyo; S Bernal; R Espigares; M Núñez; A Escribano; J L Barrionuevo; J Gentil; V Barrios; A Fernández-Nistal; G A Martos-Moreno; V Martínez; J Argente
Journal:  J Endocrinol Invest       Date:  2010-07-13       Impact factor: 4.256

6.  Serum leptin levels in acromegalic patients before and during somatostatin analogs therapy.

Authors:  R Baldelli; C Durante; E D'Amico; F Diacono; G Tamburrano; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

7.  Serum leptin levels are independently related to the incidence of ischemic heart disease in a prospective study of patients with type 2 diabetes.

Authors:  Camilla Vavruch; Toste Länne; Mats Fredrikson; Torbjörn Lindström; Carl Johan Östgren; Fredrik H Nystrom
Journal:  Cardiovasc Diabetol       Date:  2015-05-22       Impact factor: 9.951

8.  Lower leptin levels in young non-obese male smokers than non-smokers.

Authors:  Bayram Koc; Fatih Bulucu; Nuri Karadurmus; Mustafa Sahin
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

9.  Serum leptin levels in women with immunological recurrent abortion.

Authors:  Zarei Saeed; Soltanghoraee Haleh; Mohammadzadeh Afsaneh; Arefi Soheila; Zarnani Amir Hassan; Idali Farah; Tavangar Banafsheh; Savadi Shiraz Elham; Moshref Behzad Narges; Jeddi-Tehrani Mahmood
Journal:  J Reprod Infertil       Date:  2010-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.